NCT01541956 Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION) Status COMPLETED Phase PHASE4
NCT01541215 Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01529593 Temsirolimus in Combination With Metformin in Patients With Advanced Cancers Status TERMINATED Phase PHASE1
NCT01528254 VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01528046 Metformin in Children With Relapsed or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT01525823 Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin Status COMPLETED Phase PHASE1
NCT01524705 FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) Status COMPLETED Phase PHASE4
NCT01521624 Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients Status COMPLETED Phase NA
NCT01519674 Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin Status COMPLETED Phase PHASE4
NCT01518101 Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications Status COMPLETED Phase PHASE4
NCT01517412 Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin Status COMPLETED Phase PHASE3
NCT01512979 Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01511198 Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent Status COMPLETED Phase PHASE2
NCT01511172 Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01509001 Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01505426 A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients Status COMPLETED Phase PHASE3
NCT01490658 Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01489644 Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01488552 Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2